trial · primary record
BPL-1357 IM
Influenza
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 129 |
| Primary completion | 2028-03-01 |
| Primary endpoint | Safety (solicited AEs 7 days after vaccination, unsolicited adverse events (AEs) within 28 days post-vaccination, serious AEs (SAEs) |
| Registry ID | NCT07215858 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:53.440Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07215858
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.